European Urology Supplements
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma
European Urology Supplements - Tập 7 - Trang 593-600 - 2008
Conservative Treatment of Patients with Neurogenic Bladder
European Urology Supplements - Tập 7 - Trang 557-565 - 2008
Anatomical Extent of Pelvic Lymphadenectomy in Bladder and Prostate Cancer
European Urology Supplements - Tập 4 - Trang 15-24 - 2005
Critical Evaluation of the Efficacy and Safety of Anticholinergics in Overactive Bladder
European Urology Supplements - Tập 6 - Trang 425 - 2007
Antimuscarinic agents are the primary pharmacologic treatment of overactive bladder (OAB), and objective clinical data are available in a range of formats including head-to-head studies, systematic reviews and adjusted indirect comparisons. This paper reexamines the various data available on the safety and efficacy of the antimuscarinics. Clinical studies determine whether one treatment is better ...... hiện toàn bộ
#Antimuscarinics #Overactive bladder #Incontinence #Clinical evidence #Safety #Efficacy
Treatment Options in Prostate Cancer Once Primary Therapy Fails
European Urology Supplements - Tập 6 - Trang 344-353 - 2007
The Continuing Role of PSA in the Detection and Management of Prostate Cancer
European Urology Supplements - Tập 6 - Trang 327-333 - 2007
Treatment of Symptomatic Benign Prostatic Hyperplasia: Current and Future Clinical Practice in Europe – What is Really Happening?
European Urology Supplements - Tập 6 - Trang 446-453 - 2007
Risk-Adapted Management of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumours
European Urology Supplements - Tập 5 - Trang 525-532 - 2006
Diagnostic Strategies for Prostate Cancer
European Urology Supplements - Tập 10 - Trang e26-e37 - 2011
Tổng số: 289
- 1
- 2
- 3
- 4
- 5
- 6
- 10